Tsunami is correct.....
As TAVR patients over the last few years have been getting younger and younger (and so will be living longer and longer) there will be a massive market as their TAVR's need to be replaced with ViV procedures.
The DurAVR, despite not even being commercially available is already being seen as the only TAVR able to treat the 6? cases it's been involved in so far and over the next 5 years that will most likely grow to thousands and thousands and beyond that tens of thousands.
A massive market so massive $ for AVR and the DurAVR.
Ann: Update on DurAVR Valve-in-Valve Experience, page-9
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$6.03 |
Change
0.010(0.17%) |
Mkt cap ! $93.45M | |||
| Open | High | Low | Value | Volume |
| $6.00 | $6.16 | $5.80 | $52.24K | 8.792K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 857 | $5.83 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.45 | 1000 | 1 |
View Market Depth
| Last trade - 15.36pm 20/06/2025 (20 minute delay) ? |
| AVR (ASX) Chart |